SAGE Journals Online
Advertisement
Sign In to gain access to subscriptions and/or personal tools.

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement

Sign In to gain access to subscriptions and/or personal tools.
Seminars in Cardiothoracic and Vascular Anesthesia
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
1089253209347385v1
13/3/183    most recent
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Crow, S.
Right arrow Articles by Schears, R. M.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Crow, S.
Right arrow Articles by Schears, R. M.
Right arrowPubmed/NCBI databases
Medline Plus Health Information
*Heart Failure
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Extracorporeal Life Support: Utilization, Cost, Controversy, and Ethics of Trying to Save Lives

Sheri Crow, MD

Mayo Clinic, Rochester, Minnesota, crow.sheri{at}mayo.edu

Anne C. Fischer, MD, PhD

Department of Pediatric Surgery, Children's Medical Center, Dallas

Raquel M. Schears, MD, MPH

Mayo Clinic, Rochester, Minnesota

Since the first successful application of extracorporeal membrane oxygenation (ECMO) in 1972, ECMO’s role in the management of respiratory and circulatory collapse continues to be refined and debated. Randomized clinical trials aimed at establishing efficacy and patient selection criteria have been fraught with ethical challenges. Growing concerns over rising health care costs require that careful evaluations of cost, utilization, and ethical issues surrounding heroic life-saving interventions such as ECMO are undertaken. Continued analyses of ECMO’s place in the medical management of respiratory and circulatory failure will help ensure that ECMO is used for not only prolonging life but also for providing a chance for "quality of life" following recovery from near-fatal illnesses.

Key Words: extracorporeal life support • extracorporeal membrane oxygenation (ECMO) • Extracorporeal Life Support Organization (ELSO)

This version was published on September 1, 2009

Seminars in Cardiothoracic and Vascular Anesthesia, Vol. 13, No. 3, 183-191 (2009)
DOI: 10.1177/1089253209347385
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?




Advertisement